Indications
Nevanac is indicated for: prevention and treatment of postoperative pain and inflammation associated with cataract surgery; reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
Composition
- Active substance
- nepafenac
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Nevanac
- Active substance
- nepafenac
- ATC code
- S01BC10
- Group
- Sensory organs
- Therapeutic area
- Pain, Postoperative, Ophthalmologic Surgical Procedures
- Marketing authorisation holder
- Novartis Europharm Limited
- Status
- Authorised